[Leprosy and paracoccidioidomycosis].
Méndez
E de los A
Ede L
Sección Microbiología, Laboratorio Central Hosp. J.M. Cullen, Santa Fe, Argentina. emilcemendez@gigared.com
Nardin
M E
ME
Busquets
N P
NP
Lorenz
R G
RG
Iribas
J L
JL
Nagel
A A
AA
D000437:Alcoholism / Q000150:complications; D000935:Antifungal Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005148:Facial Dermatoses / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D017964:Itraconazole / Q000627:therapeutic use; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010229:Paracoccidioidomycosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011349:Proctitis / Q000175:diagnosis / Q000188:drug therapy
D000935:Antifungal Agents; D007917:Leprostatic Agents; D017964:Itraconazole